Type 4 hypersensitivity development in a case due to mifamurtide.

Simsek, Meral; Atas, Erman; Bagriaçik, Emin Ümit; Günal, Armagan; Ünay, Bülent

Simsek, Meral; Atas, Erman; Bagriaçik, Emin Ümit; Günal, Armagan; Ünay, Bülent.

Affiliation

Simsek M; Department of Pediatrics, Gülhane Faculty of Medicine, Ankara, Turkey.
Atas E; Divisions of Pediatric Hematology and Oncology, Gülhane Faculty of Medicine, Ankara, Turkey.
Bagriaçik EÜ; Department of Immunology, Gazi University Faculty of Medicine, Ankara, Turkey.
Günal A; Department of Pathology, University of Health Sciences, Gülhane Faculty of Medicine, Ankara, Turkey.
Ünay B; Divisions of Pediatric Neurology, Gülhane Faculty of Medicine, Ankara, Turkey.

Turk J Pediatr ; 62(4): 694-699, 2020.

Article in En | MEDLINE | ID: mdl-32779428

Subject(s)

Bone Neoplasms; Osteosarcoma; Pleural Effusion; Acetylmuramyl-Alanyl-Isoglutamine/analogs & derivatives; Humans; Phosphatidylethanolamines; Pleural Effusion/chemically induced

Key words

child; hypersensitivity; mifamurtide; osteosarcoma; pericardial effusion; pleural effusion

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Effusion / Bone Neoplasms / Osteosarcoma Type of study: Guideline Limits: Humans Language: En Journal: Turk J Pediatr Year: 2020 Document type: Article Affiliation country: Turkey Country of publication: Turkey

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google